FDA To Study Impact Of Rx Drug Ads That Provide Disease Information
This article was originally published in The Pink Sheet Daily
The agency plans to assess whether the inclusion of disease information in an Rx drug print ad affects consumer perception about the product.
You may also be interested in...
FDA to assess whether claims such as '#1 prescribed' affect consumer views of drug product; project to cost $529,742. Chart notes price tag for 18 other DTC studies.
The agency has 11 research projects under way, including a $2 million study of online Rx drug promotion; pharma spending on direct-to-consumer advertising declined in 2012 with biggest spends on Cymbalta and Cialis ads.
FDA expects to see an increase in direct-to-consumer drug comparison ads after the Agency for Healthcare Research and Quality completes its comparative effectiveness compendium.